Cargando…

The site of breast cancer metastases dictates their clonal composition and reversible transcriptomic profile

Intratumoral heterogeneity is a driver of breast cancer progression, but the nature of the clonal interactive network involved in this process remains unclear. Here, we optimized the use of optical barcoding to visualize and characterize 31 cancer subclones in vivo. By mapping the clonal composition...

Descripción completa

Detalles Bibliográficos
Autores principales: Berthelet, Jean, Wimmer, Verena C., Whitfield, Holly J., Serrano, Antonin, Boudier, Thomas, Mangiola, Stefano, Merdas, Michal, El-Saafin, Farrah, Baloyan, David, Wilcox, Jordan, Wilcox, Steven, Parslow, Adam C., Papenfuss, Anthony T., Yeo, Belinda, Ernst, Matthias, Pal, Bhupinder, Anderson, Robin L., Davis, Melissa J., Rogers, Kelly L., Hollande, Frédéric, Merino, Delphine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for the Advancement of Science 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8262813/
https://www.ncbi.nlm.nih.gov/pubmed/34233875
http://dx.doi.org/10.1126/sciadv.abf4408
_version_ 1783719254065938432
author Berthelet, Jean
Wimmer, Verena C.
Whitfield, Holly J.
Serrano, Antonin
Boudier, Thomas
Mangiola, Stefano
Merdas, Michal
El-Saafin, Farrah
Baloyan, David
Wilcox, Jordan
Wilcox, Steven
Parslow, Adam C.
Papenfuss, Anthony T.
Yeo, Belinda
Ernst, Matthias
Pal, Bhupinder
Anderson, Robin L.
Davis, Melissa J.
Rogers, Kelly L.
Hollande, Frédéric
Merino, Delphine
author_facet Berthelet, Jean
Wimmer, Verena C.
Whitfield, Holly J.
Serrano, Antonin
Boudier, Thomas
Mangiola, Stefano
Merdas, Michal
El-Saafin, Farrah
Baloyan, David
Wilcox, Jordan
Wilcox, Steven
Parslow, Adam C.
Papenfuss, Anthony T.
Yeo, Belinda
Ernst, Matthias
Pal, Bhupinder
Anderson, Robin L.
Davis, Melissa J.
Rogers, Kelly L.
Hollande, Frédéric
Merino, Delphine
author_sort Berthelet, Jean
collection PubMed
description Intratumoral heterogeneity is a driver of breast cancer progression, but the nature of the clonal interactive network involved in this process remains unclear. Here, we optimized the use of optical barcoding to visualize and characterize 31 cancer subclones in vivo. By mapping the clonal composition of thousands of metastases in two clinically relevant sites, the lungs and liver, we found that metastases were highly polyclonal in lungs but not in the liver. Furthermore, the transcriptome of the subclones varied according to their metastatic niche. We also identified a reversible niche-driven signature that was conserved in lung and liver metastases collected during patient autopsies. Among this signature, we found that the tumor necrosis factor–α pathway was up-regulated in lung compared to liver metastases, and inhibition of this pathway affected metastasis diversity. These results highlight that the cellular and molecular heterogeneity observed in metastases is largely dictated by the tumor microenvironment.
format Online
Article
Text
id pubmed-8262813
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher American Association for the Advancement of Science
record_format MEDLINE/PubMed
spelling pubmed-82628132021-07-16 The site of breast cancer metastases dictates their clonal composition and reversible transcriptomic profile Berthelet, Jean Wimmer, Verena C. Whitfield, Holly J. Serrano, Antonin Boudier, Thomas Mangiola, Stefano Merdas, Michal El-Saafin, Farrah Baloyan, David Wilcox, Jordan Wilcox, Steven Parslow, Adam C. Papenfuss, Anthony T. Yeo, Belinda Ernst, Matthias Pal, Bhupinder Anderson, Robin L. Davis, Melissa J. Rogers, Kelly L. Hollande, Frédéric Merino, Delphine Sci Adv Research Articles Intratumoral heterogeneity is a driver of breast cancer progression, but the nature of the clonal interactive network involved in this process remains unclear. Here, we optimized the use of optical barcoding to visualize and characterize 31 cancer subclones in vivo. By mapping the clonal composition of thousands of metastases in two clinically relevant sites, the lungs and liver, we found that metastases were highly polyclonal in lungs but not in the liver. Furthermore, the transcriptome of the subclones varied according to their metastatic niche. We also identified a reversible niche-driven signature that was conserved in lung and liver metastases collected during patient autopsies. Among this signature, we found that the tumor necrosis factor–α pathway was up-regulated in lung compared to liver metastases, and inhibition of this pathway affected metastasis diversity. These results highlight that the cellular and molecular heterogeneity observed in metastases is largely dictated by the tumor microenvironment. American Association for the Advancement of Science 2021-07-07 /pmc/articles/PMC8262813/ /pubmed/34233875 http://dx.doi.org/10.1126/sciadv.abf4408 Text en Copyright © 2021 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution NonCommercial License 4.0 (CC BY-NC). https://creativecommons.org/licenses/by-nc/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial license (https://creativecommons.org/licenses/by-nc/4.0/) , which permits use, distribution, and reproduction in any medium, so long as the resultant use is not for commercial advantage and provided the original work is properly cited.
spellingShingle Research Articles
Berthelet, Jean
Wimmer, Verena C.
Whitfield, Holly J.
Serrano, Antonin
Boudier, Thomas
Mangiola, Stefano
Merdas, Michal
El-Saafin, Farrah
Baloyan, David
Wilcox, Jordan
Wilcox, Steven
Parslow, Adam C.
Papenfuss, Anthony T.
Yeo, Belinda
Ernst, Matthias
Pal, Bhupinder
Anderson, Robin L.
Davis, Melissa J.
Rogers, Kelly L.
Hollande, Frédéric
Merino, Delphine
The site of breast cancer metastases dictates their clonal composition and reversible transcriptomic profile
title The site of breast cancer metastases dictates their clonal composition and reversible transcriptomic profile
title_full The site of breast cancer metastases dictates their clonal composition and reversible transcriptomic profile
title_fullStr The site of breast cancer metastases dictates their clonal composition and reversible transcriptomic profile
title_full_unstemmed The site of breast cancer metastases dictates their clonal composition and reversible transcriptomic profile
title_short The site of breast cancer metastases dictates their clonal composition and reversible transcriptomic profile
title_sort site of breast cancer metastases dictates their clonal composition and reversible transcriptomic profile
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8262813/
https://www.ncbi.nlm.nih.gov/pubmed/34233875
http://dx.doi.org/10.1126/sciadv.abf4408
work_keys_str_mv AT bertheletjean thesiteofbreastcancermetastasesdictatestheirclonalcompositionandreversibletranscriptomicprofile
AT wimmerverenac thesiteofbreastcancermetastasesdictatestheirclonalcompositionandreversibletranscriptomicprofile
AT whitfieldhollyj thesiteofbreastcancermetastasesdictatestheirclonalcompositionandreversibletranscriptomicprofile
AT serranoantonin thesiteofbreastcancermetastasesdictatestheirclonalcompositionandreversibletranscriptomicprofile
AT boudierthomas thesiteofbreastcancermetastasesdictatestheirclonalcompositionandreversibletranscriptomicprofile
AT mangiolastefano thesiteofbreastcancermetastasesdictatestheirclonalcompositionandreversibletranscriptomicprofile
AT merdasmichal thesiteofbreastcancermetastasesdictatestheirclonalcompositionandreversibletranscriptomicprofile
AT elsaafinfarrah thesiteofbreastcancermetastasesdictatestheirclonalcompositionandreversibletranscriptomicprofile
AT baloyandavid thesiteofbreastcancermetastasesdictatestheirclonalcompositionandreversibletranscriptomicprofile
AT wilcoxjordan thesiteofbreastcancermetastasesdictatestheirclonalcompositionandreversibletranscriptomicprofile
AT wilcoxsteven thesiteofbreastcancermetastasesdictatestheirclonalcompositionandreversibletranscriptomicprofile
AT parslowadamc thesiteofbreastcancermetastasesdictatestheirclonalcompositionandreversibletranscriptomicprofile
AT papenfussanthonyt thesiteofbreastcancermetastasesdictatestheirclonalcompositionandreversibletranscriptomicprofile
AT yeobelinda thesiteofbreastcancermetastasesdictatestheirclonalcompositionandreversibletranscriptomicprofile
AT ernstmatthias thesiteofbreastcancermetastasesdictatestheirclonalcompositionandreversibletranscriptomicprofile
AT palbhupinder thesiteofbreastcancermetastasesdictatestheirclonalcompositionandreversibletranscriptomicprofile
AT andersonrobinl thesiteofbreastcancermetastasesdictatestheirclonalcompositionandreversibletranscriptomicprofile
AT davismelissaj thesiteofbreastcancermetastasesdictatestheirclonalcompositionandreversibletranscriptomicprofile
AT rogerskellyl thesiteofbreastcancermetastasesdictatestheirclonalcompositionandreversibletranscriptomicprofile
AT hollandefrederic thesiteofbreastcancermetastasesdictatestheirclonalcompositionandreversibletranscriptomicprofile
AT merinodelphine thesiteofbreastcancermetastasesdictatestheirclonalcompositionandreversibletranscriptomicprofile
AT bertheletjean siteofbreastcancermetastasesdictatestheirclonalcompositionandreversibletranscriptomicprofile
AT wimmerverenac siteofbreastcancermetastasesdictatestheirclonalcompositionandreversibletranscriptomicprofile
AT whitfieldhollyj siteofbreastcancermetastasesdictatestheirclonalcompositionandreversibletranscriptomicprofile
AT serranoantonin siteofbreastcancermetastasesdictatestheirclonalcompositionandreversibletranscriptomicprofile
AT boudierthomas siteofbreastcancermetastasesdictatestheirclonalcompositionandreversibletranscriptomicprofile
AT mangiolastefano siteofbreastcancermetastasesdictatestheirclonalcompositionandreversibletranscriptomicprofile
AT merdasmichal siteofbreastcancermetastasesdictatestheirclonalcompositionandreversibletranscriptomicprofile
AT elsaafinfarrah siteofbreastcancermetastasesdictatestheirclonalcompositionandreversibletranscriptomicprofile
AT baloyandavid siteofbreastcancermetastasesdictatestheirclonalcompositionandreversibletranscriptomicprofile
AT wilcoxjordan siteofbreastcancermetastasesdictatestheirclonalcompositionandreversibletranscriptomicprofile
AT wilcoxsteven siteofbreastcancermetastasesdictatestheirclonalcompositionandreversibletranscriptomicprofile
AT parslowadamc siteofbreastcancermetastasesdictatestheirclonalcompositionandreversibletranscriptomicprofile
AT papenfussanthonyt siteofbreastcancermetastasesdictatestheirclonalcompositionandreversibletranscriptomicprofile
AT yeobelinda siteofbreastcancermetastasesdictatestheirclonalcompositionandreversibletranscriptomicprofile
AT ernstmatthias siteofbreastcancermetastasesdictatestheirclonalcompositionandreversibletranscriptomicprofile
AT palbhupinder siteofbreastcancermetastasesdictatestheirclonalcompositionandreversibletranscriptomicprofile
AT andersonrobinl siteofbreastcancermetastasesdictatestheirclonalcompositionandreversibletranscriptomicprofile
AT davismelissaj siteofbreastcancermetastasesdictatestheirclonalcompositionandreversibletranscriptomicprofile
AT rogerskellyl siteofbreastcancermetastasesdictatestheirclonalcompositionandreversibletranscriptomicprofile
AT hollandefrederic siteofbreastcancermetastasesdictatestheirclonalcompositionandreversibletranscriptomicprofile
AT merinodelphine siteofbreastcancermetastasesdictatestheirclonalcompositionandreversibletranscriptomicprofile